17 beta-Estradiol/Progesterone in a Single Oral Softgel Capsule (TX-001HR) Significantly Reduced Moderate-to-Severe Vasomotor Symptoms without Endometrial Hyperplasia Meeting Abstract

sustainable development goals

authors

publication date

  • December 1, 2017

webpage

published in

start page

  • 1430

end page

  • +

volume

  • 24

issue

  • 12